RANI
Rani Therapeutics Holdings, Inc.
Key Financials
Net Income
$-29673000
↑ 1.1%
Operating Income
$-38310000
↑ 28.1%
Revenue
$1.6M
↑ 58.9%
Total Assets
$58.6M
↑ 60.0%
EPS (Diluted)
$-0.45
↑ 57.1%
Total Liabilities
$17.1M
↓ 48.4%
Cash & Equivalents
$18.6M
↑ 394.9%
Shareholders' Equity
$33.0M
↑ 1557.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G | 4/30/2026 | View on SEC |
| ARS | 4/16/2026 | View on SEC |
| DEFA14A | 4/16/2026 | View on SEC |
| DEF 14A | 4/16/2026 | View on SEC |
| 3 | 3/27/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| S-8 | 3/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RANI |
| Company Name | Rani Therapeutics Holdings, Inc. |
| CIK | 1856725 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | CA |
| Phone | (408) 457-3700 |